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Abstract
Objective:  to  assess  whether  25hydroxivitaminD  or  25(OH)vitD  deﬁciency  has  a  high  prevalence
at pediatric  intensive  care  unit  (PICU)  admission,  and  whether  it  is  associated  with  increased
prediction  of  mortality  risk  scores.
Method: prospective  observational  study  comparing  25(OH)vitD  levels  measured  in  156  patients
during  the  12  hours  after  critical  care  admission  with  the  25(OH)vitD  levels  of  289  healthy
children.  25(OH)vitD  levels  were  also  compared  between  PICU  patients  with  pediatric  risk  of
mortality  III  (PRISM  III)  or  pediatric  index  of  mortality  2  (PIM  2)  >  p75  [(group  A;  n  =  33)  vs.  the
others  (group  B;  n  =  123)].  Vitamin  D  deﬁciency  was  deﬁned  as  <  20  ng/mL  levels.
Results: median  (p25-p75)  25(OH)vitD  level  was  26.0  ng/mL  (19.2-35.8)  in  PICU  patients  vs.
30.5  ng/mL  (23.2-38.6)  in  healthy  children  (p  =  0.007).  The  prevalence  of  25(OH)vitD  <  20  ng/mL
was  29.5%  (95%  CI:  22.0-37.0)  vs.  15.6%  (95%  CI:  12.2-20.0)  (p  =  0.01).  Pediatric  intensive
care  patients  presented  an  odds  ratio  (OR)  for  hypovitaminosis  D  of  2.26  (CI  95%:  1.41-3.61).
25(OH)vitD  levels  were  25.4  ng/mL  (CI  95%:  15.5-36.0)  in  group  A  vs.  26.6  ng/mL  (CI  95%:
19.3-35.5)  in  group  B  (p  =  0.800).
Conclusions:  hypovitaminosis  D  incidence  was  high  in  PICU  patients.  Hypovitaminosis  D  was  not
associated  with  higher  prediction  of  risk  mortality  scores.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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PALAVRAS-CHAVE
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prognósticos;
Risco de  mortalidade
Deﬁciência  de  vitamina  D  em  internac¸ões  na  unidade  de  terapia  intensiva  pediátrica
Resumo
Objetivo:  avaliar  se  a  deﬁciência  da  25-hidroxivitamina  D,  ou  25  (OH)  vitD,  tem  prevalência
elevada em  internac¸ões  na  unidade  de  terapia  intensiva  pediátrica,  e  se  estaria  relacionada  à
previsão  de  escores  de  risco  de  mortalidade.
Método:  estudo  observacional  prospectivo  comparando  níveis  de  25  (OH)  vitD  de  156  pacientes,
mensurados nas  primeiras  12  horas  da  internac¸ão  em  terapia  intensiva,  com  níveis  de  25  (OH)
vitD  de  289  crianc¸as  saudáveis.  Os  níveis  de  25  (OH)  vitD  também  foram  comparados  entre
pacientes  na  UTIP  com  escore  PRISM  III  ou  PIM  2  >  p75  (Grupo  A;  n  =  33),  e  o  restante,  (Grupo
B;  n  =  123).  A  deﬁciência  de  vitamina  D  foi  deﬁnida  como  níveis  <  20  ng/mL.
Resultados: o  nível  médio  (p25-p75)  de  25  (OH)  vitD  foi  26,0  ng/mL  (19,2-35,8)  em  pacientes
internados na  UTIP,  em  comparac¸ão  a  30,5  ng/mL  (23,2-38,6)  em  crianc¸as  saudáveis  (p  =  0,007).
A  prevalência  de  25  (OH)  vitD  <  20  ng/mL  foi  de  29,5%  (IC  95%,  22,0-37,0),  em  comparac¸ão  a
15,6%  (IC  95%,12,2-20,0)  (p  =  0,01).  Os  pacientes  em  terapia  intensiva  pediátrica  apresentaram
uma  razão  de  chance  (RC)  para  hipovitaminose  D  de  2,26  (IC  95%,  1,41-3,61).  Os  níveis  de  25
(OH)  vitD  foram  25,4  ng/mL  (IC  95%,  15,5-36,0)  no  grupo  A,  em  comparac¸ão  a  26,6  ng/mL  (IC
95%,  19,3-35,5)  no  grupo  B  (p  =  0,800).
Conclusões:  a  incidência  de  hipovitaminose  D  foi  elevada  em  pacientes  em  terapia  intensiva
pediátrica, mas  não  foi  associada  à  maior  previsão  de  escores  de  risco  de  mortalidade.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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ow  levels  of  vitamin  D  are  common  in  adult  and  pedi-
tric populations.1 Vitamin  D  deﬁciency  has  been  classically
elated with  osseous  illness,  such  as  rickets.  Currently,
itamin D  deﬁciency  is  considered  to  be  related  with  over-
ll mortality,2 prevention  of  infections,  innate  immunity,3
ypertension,4 hypertriglyceridemia,  type  1  and  2  diabetes
ellitus,5 neoplasms,6 and  autoimmune  disorders.7 In  chil-
ren, it  has  been  related  to  severe  asthma,  bronchiolitis
pisodes, and  lower  response  to  corticoids.8
The  most  important  source  of  vitamin  D  is  the  skin,
hrough the  action  of  ultraviolet  B  radiation  on  7dehy-
rocholesterol. Vitamin  D  must  be  metabolized  to  25
ydroxivitamin D  (25(OH)vitD)  in  the  liver,  which  is  an  inac-
ive precursor  with  a  half-life  of  approximately  two  to  three
eeks. The  half-life  of  the  active  form  (1,25(OH)vitD)  is
nly four  to  24  hours.9 For  that  reason,  25  (OH)vitD  has  been
he most  common  form  of  vitamin  D  measured  in  previous
tudies10 In  healthy  children,  age,  skin  pigmentation,  season
f the  year,  sun  exposure,  and  dietary  calcium  intake  inﬂu-
nce 25(OH)vitD  concentrations.  Most  studies  have  adopted
he deﬁnition  of  vitamin  D  insufﬁciency  as  25(OH)vitD  con-
entrations lower  than  30  ng/mL,  and  vitamin  D  deﬁciency
s concentrations  below  20  ng/mL.10
Recently,  vitamin  D  deﬁciency  has  been  associated  with
igher illness  severity  upon  admission,  mortality,  and  worse
hort and  long  term  outcomes  in  adult  intensive  care  units
ICU) patients.11--13 Several  studies14--16 provided  new  infor-
ation regarding  the  relationship  between  vitamin  D  status
nd critical  illnesses  in  children  admitted  to  pediatric  ICUs
PICUs). It  was  observed  that  hypovitaminosis  D  is  a  common
nding in  critically-ill  children.  McNally  et  al.16 also  reported
hat vitamin  D  deﬁciency  was  associated  with  greater  sever-
ty of  critical  illness.  However,  Rippel  et  al.14 did  not  ﬁnd  an
l
i
s
sssociation  between  hypovitaminosis  D  and  length  of  stay
r hospital  survival.  Vitamin  D  status  may  play  an  important
ole in  acute  stress  and  critical  illness,  but  its  pleiotropic
ffects in  acute  illness  are  not  completely  understood.  Many
onfounding factors  (hemodilution,  interstitial  extravasa-
ion, decreased  synthesis  of  binding  proteins,  renal  wasting
f 25(OH)vitD,  pH,  underlying  disease,  season  of  the  year,
ge, and  dietary  supplementation,  among  others)  inﬂuence
itamin D  status  during  critical  illness.17 To  date,  there
s no  consensus  regarding  the  optimal  deﬁnitions  of  vita-
in D  deﬁciency,  nor  the  threshold  levels  to  deﬁne  health
eneﬁts.17,18
Therefore,  this  study  aimed  to  investigate  whether  vita-
in D  deﬁciency  is  highly  prevalent  in  patients  admitted  to  a
ICU. The  secondary  objective  was  to  verify  whether  vitamin
 deﬁciency  would  be  associated  with  increased  mortality
isk scores  and  illness  severity  at  PICU  admission.
atients and methods
his  study  was  a  secondary  analysis  of  data  and  biological
amples collected  as  part  of  the  new  prognosis  biomark-
rs investigation,  a  prospective  observational  study  set  in
he eight-bed  PICU  of  the  Hospital  Universitario  Central  de
sturias, in  Oviedo,  Spain.  The  study  protocol  was  approved
y the  Hospital  Ethics  Committee.  The  study  was  conducted
n 156  patients  admitted  to  the  PICU  and  aged  less  than
6 years.  The  exclusion  criteria  were  no  blood  extraction
uring the  ﬁrst  12  hours  after  admission;  lack  of  consent
o participate  by  parents  or  by  children  older  than  12
ears; known  or  suspected  adrenal,  pituitary,  or  hypotha-
amic disease;  and  use  of  systemic  steroids  for  >  ten  days
n the  previous  month,  or  more  than  one  dose  of  systemic
teroids within  24  hours  of  admission  (except  for  dexametha-
one).
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On  every  blood  test  sampled  in  the  ﬁrst  12  hours  after
admission, the  following  variables  were  recorded:  age,
weight, underlying  disease,  and  diagnosis.  Respiratory  rate,
heart rate,  blood  pressure,  O2 saturation,  urine  rate,  and
administration of  vasopressor  agents  were  recorded  hourly.
Radiographic and  microbiologic  diagnostics  were  performed
when indicated.  Blood  cultures  were  performed  when  there
was clinical  suspicion  of  infection  or  when  the  patient’s
temperature was  >  38 ◦C.  The  pediatric  index  of  mortal-
ity 2  (PIM  2)  value  was  calculated  at  admission,  and  the
pediatric risk  of  mortality  III  (PRISM  III)  value  was  calcu-
lated during  the  ﬁrst  12  h  after  admission,  as  it  was  the
normal clinical  practice.  Routine  biochemical  assays,  includ-
ing C-reactive  protein  (CRP)  and  procalcitonin  (PCT),  were
performed during  the  ﬁrst  12  hours  after  admission.  Venous
blood samples  were  collected  in  tubes  containing  ethylene-
diamine-tetra-acetic acid  (EDTA).  A  plasma  aliquot  was
frozen and  stored  at  -80 ◦C  for  further  determination  of
25(OH)vitD, mid-regional  pro-adrenomedullin  (MR-proADM),
and carboxy-terminal  pro-endothelin-1  (CT-proET-1).
Healthy  children
The  25(OH)vitD  levels  of  the  PICU  patients  were  compared
with the  25(OH)vitD  levels  that  were  obtained  as  part  of
a study  on  vitamin  D  status  that  is  currently  under  devel-
opment in  a  population  of  healthy  children  from  the  city
of Oviedo  (Asturias,  Spain).  Data  from  289  healthy  children
were obtained.
Deﬁnition  of  hypovitaminosis  D
Vitamin  D  deﬁciency  was  deﬁned  as  <  20  ng/mL  25(OH)vitD
levels.10
Mortality risk groups
Patients  were  divided  in  two  groups  according  to  mortality
risk scores.  Higher  risk  mortality  group  (group  A)  included
patients with  a  PIM  2  or  PRISM  III  score  >  p75  (n  =  33);  lower
risk mortality  group  (group  B)  comprised  the  remaining
patients (n  =  123).
Measurement  of  25(OH)vitD,  CRP,  PCT,
MR-proADM, and  CT-proET-1
Serum  25(OH)vitD  was  measured  using  a  direct  competitive
chemiluminescence immunoassay  (LIAISON®  Analyzer).  The
assay range  is  4.0  to  150  ng/mL.  Plasma  CRP  was  measured
on a  Modular  Analytics  Cobacs  6000  (Roche  Diagnostics  - IN,
USA) using  an  immunoturbidimetric  technique.  The  analyti-
cal detection  limit  was  0.07  mg/dL.
MR-proADM, CT-proET-1,  and  PCT  were  measured  in  EDTA
plasma using  a  sandwich  immunoassay  (TRACE  technology;
Brahms -  Hennigsdorf,  Germany).  Analytical  detection  limits
were  0.08  nmol/L  for  pro-ADM,  0.4  pmol/L  for  CT-proET-1,
and 0.02  ng/mL  for  PCT.
=
2
(
l137
tatistical  analysis
atients’  clinical  and  biological  parameters  were  described
sing frequencies,  percentages,  means,  medians,  and  ranges
p25-p75).  Groups  of  patients  were  compared  using  the
ann--Whitney U-test  for  continuous  variables,  and  cross
ables and  exact  chi-squared  test  were  used  for  categorical
ata. Adjusted  odds  ratios  (OR)  were  estimated  by  mul-
ivariate logistic  regression  analysis  (step-forward  criteria
ncluding all  relevant  likelihood  ratio  based  variables).  A
-value <  0.05  was  considered  as  statistically  signiﬁcant.
esults
aseline  characteristics
his  study  comprised  156  PICU  patients.  Baseline  demo-
raphic, clinical,  and  laboratory  characteristics  of  the  PICU
atients are  shown  in  Table  1.  The  main  reasons  for  PICU
dmission were  postoperative  and  respiratory  and  infectious
isease. Seventy-six  patients  (48.7%)  were  younger  than  4
ears.
ypovitaminosis  D  incidence
emographic  and  vitamin  D  data  in  the  PICU  population  and
ealthy children  are  reported  in  Table  1.  25(OH)vitD  lev-
ls were  lower  and  the  incidence  of  hypovitaminosis  D  was
igher in  the  PICU  population.  Vitamin  D  values  in  criti-
ally ill  children  had  a  negative  correlation  with  patient’s
ge (Spearman’s  correlation  coefﬁcient:  -0.421;  p  <  0.001).
herefore, vitamin  D  deﬁciency  was  compared  between
ealthy and  PICU  children  in  different  age  groups  (Table  2).
he incidence  of  vitamin  D  deﬁciency  increased  with  age
n both  groups  of  patients.  PICU  patients  had  a  crude  OR
or hypovitaminosis  D  of  2.26  (CI  95%:  1.41-3.61).  The  age,
eight, and  gender-adjusted  OR  was  1.83  (CI  95%:  1.10-
.06).
Median (p25-p75)  25(OH)vitD  levels  during  the  differ-
nt seasons  of  the  year  in  PICU  patients  were:  spring,
0.1 ng/mL  (18.2-36.5);  summer,  28.1  ng/mL  (20.5-33.3);
all, 24.9  ng/mL  (19.6-39.0);  and  winter,  23.0  ng/mL  (15.4-
8.0), p  =  0.761.
Baseline demographic,  clinical,  and  laboratory  charac-
eristics of  the  PICU  vitamin  D  deﬁcient  group  vs.  the
emainder of  the  PICU  sample  are  shown  in  Table  3.  Vita-
in D  deﬁcient  patients  were  older  and  heavier.  PICU  stay,
notropic support,  and  need  for  mechanical  ventilation  and
on-invasive ventilation  showed  no  difference  between  both
roups. Respiratory  diagnosis  at  admission  was  less  frequent
n vitamin  D  deﬁcient  patients,  whereas  metabolic-renal
iagnosis was  more  common.  Underlying  disease  incidence
as higher  in  hypovitaminosis  D  patients  (47.8%  vs.  36.3%;  p 0.132  (Table  3).  Median  (p25-p75)  25(OH)vitD  levels  were
3.4 ng/m  (18.6-33-3)  in  patients  with  underlying  disease
n =  62)  vs.  30.1  ng/mL  (20.0-39.3)  in  patients  without  under-
ying disease  (n  =  94);  (p  =  0.039).
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Table  1  Demographic  and  vitamin  D  data  in  healthy  children  and  in  PICU  population  (median,  p25-p75).
Demographic  and  vitamin  D  data  Healthy  children  (n  =  289)  PICU  population  (n  =  156)  p-value
Age  at  admission  (months) 36.0  (24.0-84.0)  46.0  (15.2-116.7)  0.678
Weight (kg)  16.5  (12.0-28.0)  16.0  (11.0-33.0)  0.120
Gender, male,  n  (%)  166  (57.4)  93  (59.6)  0.836
25(OH)vitD (ng/mL)  30.5  (23.2-38.6)  26.0  (19.2-35.8)  0.007
25(OH)vit D  <  20  ng/mL  (%)  15.6%  (95%  CI:  12.2-20.0)  29.5%  (95%  CI:  22.0-37.0)  0.01
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isk  of  mortality
aseline  demographic,  clinical,  and  laboratory  characteris-
ics of  the  patients  with  higher  risk  of  mortality  (group  A)  vs.
he rest  of  the  sample  are  shown  in  Table  4.  Group  A  patients
ere younger  and  lighter.  PICU  stay,  inotropic  support,  and
eed for  mechanical  ventilation  and  non-invasive  ventilation
ere higher  in  group  A.  Postoperative  diagnosis  at  admission
as less  frequent  in  group  A,  whereas  respiratory  diagnosis
as more  frequent.  PCT,  MR-proADM,  and  CT-proET-1  plasma
evels were  signiﬁcantly  higher  in  patients  with  higher  pre-
iction of  mortality  risk  scores,  whereas  CRP  and  25OH(vitD)
evels were  no  different  between  groups  A  and  B.
Additional  evaluation  using  a  multivariate  logistic  regres-
ion analysis  found  an  adjusted  OR  by  age,  season,  and
nderlying disease  of  2.42  (95%  CI:  0.86-6.84)  for  vitamin  D
eﬁciency and  prediction  of  mortality  risk  scores  (p  =  0.09).
iscussion
his  study  demonstrated  that,  in  a  sample  of  critically  ill
hildren from  the  north  of  Spain,  the  prevalence  of  hypovi-
aminosis D  was  high  at  PICU  admission.  The  present  study
upports recent  investigations14--16 showing  that  hypovita-
inosis D is  common  in  critically  ill  children.  It  was  observed
hat 29.5%  of  the  present  PICU  patients  had  25(OH)vitD  <
0 ng/mL,  similar  to  the  rate  of  34.5%  from  the  study  by  Rip-
el et  al.14 in  a  cohort  of  critically  ill  Australian  children,  and
ower than  the  40.1%  and  69%  reported  by  Madden  et  al.15
nd  by  McNally  et  al.16 in  North  American  and  Canadian
hildren, respectively.
t
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Table  2  Vitamin  D  deﬁciency  (25(OH)vit  D  <  20  ng/mL)  in  healthy
Age  group  Healthy  children  (n  =  289)  
<  1  year  (n  =  46)
6.5% (95%  CI:
1.4-17.9)
1-5 years  (n  =  156)
12.8% (95%  CI:
7.3-18.4)
> 5  years  (n  =  87)
26.2% (95%  CI:
16.2-36.2)
CI, conﬁdence interval; PICU, pediatric intensive care unit; 25 (OH)vitD, 25 hydroxivitamin D.
The25(OH)vitD  levels  from  the  present  PICU  patients
ere compared  with  the  25(OH)vitD  levels  that  were
btained as  part  of  a  study  on  vitamin  D  status  that  is  cur-
ently under  development  in  a  population  of  healthy  children
rom the  city  of  Oviedo  (Asturias,  Spain).  The  prevalence
f vitamin  D  deﬁciency  in  Oviedo’s  population  of  healthy
hildren was  similar  to  the  reported  prevalence  of  18%  in
ansbach’s population-based  study  of  healthy  North  Ameri-
an children,19 but  lower  than  the  published  prevalence  of
itamin D  deﬁciency  in  North  American  and  Australian  ado-
escents, which  ranged  from  29%  to  68%.20,21 The  explanation
or these  differences  is  the  age.  A  previously  described
nverse correlation  between  25(OH)vitD  levels  and  age  was
onﬁrmed by  the  present  study.  The  median  age  of  the
resent healthy  children  cohort  was  3  years,  much  younger
han the  adolescent  sample  from  the  United  States  and  Aus-
ralia. The  incidence  of  vitamin  D  deﬁciency  was  compared
etween healthy  and  PICU  children  in  different  age  groups
Table 2).  As  expected,  incidence  of  vitamin  D  deﬁciency
ncreased with  age  in  both  group  of  patients.  PICU  patients
ad double  incidence  of  hypovitaminosis  D  in  all  age  groups,
ut the  differences  were  clearly  statistically  signiﬁcant  in
he older  age  group,  and  were  almost  signiﬁcant  in  the
edium age  group.  The  probable  reason  is  that  the  frag-
entation of  the  sample  produced  a  small  sample  size  in
he younger  age  group.  Regarding  the  season  of  the  year,
here were  no  signiﬁcant  differences  in  25(OH)vitD  levels  in
he present  study,  although  values  tended  to  be  lower  in  fall
nd winter,  which  agree  with  previous  studies  performed  in
he North  of  Spain18 and  in  other  countries.20 In  healthy  chil-
ren, factors  consistently  associated  with  25(OH)vitD  levels
ere age,  season  of  the  year,  and  dietary  calcium  intake.22
 and  PICU  children  in  different  age  groups.
PICU  children  (n  =  156)  p-value
(n =  28)
11.1% (95%  CI:
2.4-29.2)
0.664
(n =  61)
23.3% (95%  CI:
11.8-34.9)
0.064
(n =  67)
43.1% (95%  CI:
30.3-55.9)
0.036
D, 25 hydroxivitamin D.
Vitamin  D  and  pediatric  intensive  care  139
Table  3  Demographic,  clinical,  and  laboratory  data  in  the  overall  PICU  population  and  in  patients  with  and  without  vitamin  D
deﬁciency.
25(OH)vitD  <
20 ng/mL
n  =  46
25(OH)vitD
≥ 20  ng/mL
n  =  110
p-value  Overall  PICU
population
n =  156
Demographic  and  clinical  characteristics
Age at  admission  (months)  97.0  (44.5-145.0)  34.0  (14.0-98.0)  <  0.001  46.0  (15.2-116.7)
Weight  (kg) 23.0  (14.9-44.8) 14.4  (10.0-30.0)  <  0.001  16.0  (11.0-33.0)
Gender,  Male,  n  (%) 28  (60.9) 65  (59.1) 0.860  93  (59.6)
PICU  stay  (days) 3.0  (1.0-5.0) 4.5  (2.0-7.0) 0.067 4.0  (2.0-6.0)
Mechanical  ventilation,  n  (%) 18  (39.1) 45  (40.9) 0.860 63  (40.4)
Non-invasive  ventilation,  n  (%)  7  (17.1)  16  (24.5)  0.385  33  (15.8)
Inotropic/vasopressor  support,  n  (%)  6  (13.0)  7  (6.4)  0.205  13  (8.3)
Admission  diagnosis
Postoperative  15  (33)  32  (29)  0.806  47
Respiratory  5  (10)  30  (27)  0.042  35
Infectious  6  (13)  18  (16)  0.779  24
Traumatic  2  (4)  11  (10)  0.397  13
Neurologic  1  (2)  7  (6)  0.494  8
Metabolic-renal  7  (15)  2  (2)  0.004  9
Others  10  (22)  10  (9)  0.058  20
PRISM  III,  absolute  value  3.71  ±  3.86  3.34  ±  4.67  0.629  3.4  (4.4)
PIM  2,  %  1.13  ±  1.20  2.99  ±  10.86  0.086  2.5  (9.3)
Underlying  disease,  n  (%)  22  (47.8)  40  (36.3)  0.132  62  (39.7)
Laboratory  data
pH 7.3  (7.2-7.4)  7.3  (7.3-7.4)  0.625  7.3  (7.3-7.4)
Bicarbonate  (mEq/L)  21.9  (18.7-24.2)  21.8  (19.9-23.5)  0.769  21.8  (19.7-23.7)
Lactate  (mmol/L)  1.4  (0.9-1.8)  1.3  (0.8-2.0)  0.647  1.3  (0.9-2.0)
Platelets  (X1000/mm3)  246  (185-296)  292  (214-388)  0.017  273  (200-365)
CI, conﬁdence interval; PICU, pediatric intensive care unit; PIM 2, pediatric index of mortality 2; PRISM III, pediatric risk of mortality III;
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PRISM III and PIM 2 are expressed as mean ± standard deviation, ad
as median (P25-P75).
Unfortunately,  data  regarding  children’s  calcium  intake  was
not available.
Regarding admission  diagnosis,  a  lower  respiratory  diag-
nosis rate  was  observed  in  patients  with  vitamin  D  deﬁciency.
In the  few  published  pediatric  studies,23 an  association  was
found between  vitamin  D  deﬁciency  and  lung  function,  as
well as  with  the  risk  for  upper  respiratory  tract  infections.
A higher  metabolic-renal  diagnosis  rate  in  patients  with  vita-
min  D  deﬁciency  was  also  observed.  Metabolic-renal  diseases
can negatively  inﬂuence  the  vitamin  D  metabolic  pathways,
affecting 25(OH)vitD  levels.17
In  the  present  sample,  patients  with  underlying  disease
had lower  levels  of  25(OH)vitD.  These  patients  are  at  a
higher risk  for  reduced  vitamin  D  levels  through  abnormal
diets, altered  metabolism,  or  reduced  environmental  expo-
sure.
Risk  of  mortality
Vitamin  D  deﬁciency  has  recently  been  shown  to  be
associated with  mortality  in  critically  ill  adults.11--13,24,25
Other  recent  investigations  have  not  observed  this
relationship.26,27 Considering  that  the  present  study  was
not sufﬁciently  powered  to  observe  differences  in  survival,
p
T
2
cion diagnosis as absolute value and %, and the remaining variables
ther  surrogate  markers  of  PICU  outcome  were  used,  such
s mortality  scores.  In  accordance  with  Rippel  et  al.,14 no
ssociations were  observed  between  vitamin  D  status  and
redicted PRISM  III  and  PIM  2  mortality.  However,  Madden
t al.15 and  McNally  et  al.16 demonstrated  that  25(OH)vit
 levels  at  admission  were  inversely  associated  with  PRISM
II in  North  American  children.  Furthermore,  duration  of
echanical or  non-invasive  ventilation  and  length  of  PICU
tay did  not  show  differences  between  low  and  normal
5(OH)vitD groups  in  the  present  sample,  in  agreement  with
he data  observed  by  Rippel  et  al.14 in  Australian  chil-
ren. However,  McNally  et  al.16 found  an  association  of
itamin D  deﬁciency  with  longer  length  of  stay.  Geographic
nd ethnic  differences,  as  well  as  different  causes  of  PICU
dmissions, could  explain  the  similar  results  in  the  present
tudy and  in  the  Australian  study,  and  the  differences  with
oth North  American  studies.  Variations  in  patient  responses
o acute  stress  and  critical  illness  may  depend  on  the
egree of  vitamin  D  insufﬁciency  and  the  patient’s  tissue
equirements.17
Other  prognostic  markers,  such  PCT,  MR-proADM.  and  CT-
roET-1 were  associated  with  risk  of  mortality  (Table  2).
herefore, these  biomarkers  would  have  more  utility  than
5(OH)vitD to  establish  the  risk  of  mortality  in  critically  ill
hildren.
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Table  4  Demographic,  clinical,  laboratory  data,  and  marker  levels  in  patients  with  higher  vs.  lower  prediction  of  risk  mortality
scores.
Group  A  (PRISM  III
or PIM  2  >  p75)
(n =  33)
Group B  (PRISM  III
and PIM  2  ≤  p75)
(n =  123)
p-value
Demographic  and  clinical  characteristics
Age at  admission  (months)  21.0  (8.2-56.0)  58.5  (23.2-123.5)  0.007
Weight (kg)  11.1  (8.8-20.2)  17.2  (12.0-35.4)  0.012
Gender, male,  n  (%) 22 (66.7)  71  (57.7)  0.426
PICU stay  (days) 5.0(3,0-9.5) 3.0  (2.0-  6.0) 0.008
Mechanical ventilation,  n  (%) 25 (75.8) 38  (30.9) <  0.001
Non-invasive ventilation,  n  (%) 15 (45.5) 18  (22.4) 0.001
Inotropic/vasopressor  support,  n  (%)  9  (27.3)  4  (3.3)  <0.001
Admission diagnosis
Postoperative  1  (3)  46  (37)  <  0.001
Respiratory 12  (36)  23  (19)  0.054
Infectious 6  (18)  18  (15)  0.818
Traumatic 3  (9)  10  (8)  0.859
Neurologic 3  (9)  5  (4)  0.473
Metabolic-renal 4  (12)  5  (4)  0.179
Others 4  (12)  16  (13)  0.875
PRISM III,  absolute  value  8.0  ±  6.7  2.2  ±  2.3  <  0.001
PIM 2,  %  8.6  ±  18.4  0.68  ±  0.46  0.019
Laboratory data
pH 7.3  (7.2-7.4)  7.4  (7.3-7.4)  0.012
Bicarbonate (mEq/L)  21.8  (16.6-24.1)  21.8  (19.9-23.7)  0.898
Lactate (mmol/L)  1.4  (0.97-2.1)  1.2  (0.80-2.0)  0.319
Platelets (x  1,000/mm3)  244  (163-409)  281  (214-364)  0.277
Markers
CRP (mg/dL)  2.58  (0.50-14.9)  1.05  (0.10-8.4)  0.123
PCT (ng/mL)  1.4  (0.3-10.4)  0.18  (0.07-1.3)  <  0.001
MR-proADM (nmol/L)  0.79  (0.49-1.5)  0.46  (0.33-0.60)  <  0.001
CT-proET-1 (pmol/L)  80.7  (57.6-115.9)  50.7  (35.8-75.7)  <  0.001
25(OH)vitD (ng/mL)  25.40  (15.5-36.0)  26.6  (19.3-35.5)  0.800
25(OH)vit D  <  20  ng/mL,  n  (%)  11  (33.3%)  37  (30.1%)  0.832
CRP, C-reactive protein; CT-proET-1, carboxy-terminal pro-endothelin-1; MR-proADM, mid-regional pro-adrenomedullin; PCT, procalci-
tonin; PICU, pediatric intensive care units; PIM 2, pediatric index of mortality 2; PRISM III, pediatric risk of mortality III; 25 (OH)vitD, 25
hydroxivitamin D.
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By  regulating  the  expression  of  more  than  200
enes, including  those  inﬂuencing  cell  growth,  1,25-
ihydroxyvitamin D3  plays  an  important  role  in  the
roliferation, maturation,  and  death  of  cells.  The  identi-
cation of  modiﬁable  risk  factors  could  help  to  guide  new
reventative or  therapeutic  strategies  for  pediatric  critical
llness. However,  recent  evidence17 suggests  that  the  inter-
retation of  vitamin  D  status  based  on  25(OH)vitD  levels  in
cute illness  should  be  performed  with  caution.  Signiﬁcant
ariation in  25(OH)vitD  levels  may  occur  from  hour  to  hour
n acutely  ill  patients,  and  single  point  assessment  may  be
naccurate in  certain  cases.  Moreover,  vitamin  D  deﬁciency
ould not  only  be  dependent  on  the  severity  of  vitamin  D
28epletion, but  would  also  be  related  to  tissue  requirement.
herefore  new  studies  are  necessary  in  order  to  determine
eliable markers  of  vitamin  D  status  in  the  acute  care  set-
ing, as  well  as  strategies  to  conﬁrm  whether  vitamin  D
F
1
d
rdmission diagnosis as absolute value; the other variables were
upplementation  is  useful  for  hypovitaminosis  D  in  critically
ll children.
The present  study  has  limitations.  Firstly,  parathy-
oid hormone  (PTH)  was  not  measured.  The  diagnosis
f vitamin  D  deﬁciency  usually  requires  the  association
f serum  25(OH)vitD  levels  lower  than  20  ng/mL  and
levated serum  PTH  concentrations.29 Secondly,  the  rel-
tively small  sample  size  and  the  low  mortality  limited
he capacity  to  analyze  speciﬁc  subgroup  of  patients.
hirdly, the  original  study  was  not  intended  to  esti-
ate the  prevalence  of  vitamin  D  deﬁciency;  therefore,
 speciﬁc  questionnaire  about  dietary  habits,  vitamin  D
upplementation, or  sun  exposure  was  not  performed.
inally, 25(OH)vitD  levels  were  analyzed  during  the  ﬁrst
2 hours  after  PICU  admission;  evolution  of  25(OH)vitD  levels
uring the  ﬁrst  days  of  admission  would  have  higher  accu-
acy.
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In  conclusion,  in  a  population  of  children  from  the  North
of Spain,  hypovitaminosis  D  incidence  was  high  at  PICU
admission. To  the  authors’  knowledge,  this  is  the  ﬁrst
prospective study  comparing  25(OH)vitD  levels  in  critically
ill patients  with  healthy  children  population  from  the  same
area. Hypovitaminosis  D  was  not  associated  with  higher  pre-
diction of  mortality  risk  scores,  length  of  stay,  and  inotropic
or respiratory  support.  Further  studies  are  required  to  iden-
tify reliable  markers  of  vitamin  D  status  in  the  acute  care
setting, as  well  as  strategies  to  conﬁrm  whether  vitamin  D
supplementation could  be  useful  in  critically  ill  children  with
hypovitaminosis D.
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